Trial Site Detail

 

Drug:
Nivolumab + BMS-986016
Trial:
Safety Study of Anti-LAG-3 With and Without Anti-PD-1 in the Treatment of Solid Tumors
Conditions: Solid Tumors
Trial Status:
Recruiting

 

Karmanos Cancer Institute

4100 John R     
Detroit , MI 48201
USA

 

Principal Investigator:
Contact:
Amy Weise, Site 0011 313-576-8599
Activation Status of this Site:
Active
Notes about this Site:
Karmanos Cancer Institute Website:
https://app-oncoreprod1.karmanos.org/sip/SIPControlServlet

 

 

Navigating the Map

Use the plus (+) and minus (-) controls to zoom in/out.

Click and drag the map or use the arrows to move (pan) the map.

Tip: Click the marker before zooming and the map will stay centered on the marker as you zoom.